ClinicalTrials.gg
RecruitingNCT06043596SafeSpaceUpdated Nov 21, 2023

Evaluation of the SafeSpace App Intervention

An interventional study of SafeSpace Sexual Health and SafeSpace General Health in Health Behavior, Health Care Utilization and Unprotected Sex, sponsored by Child Trends. Recruiting at 1 site in United States. Open to female participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-21.

Primary conditionPatient Acceptance of Health CareRegistry: Health BehaviorReclassifiedWhy we changed it
Registry
Health Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Patient Acceptance of Health Care
Why
  1. The study's listed conditions name Patient Acceptance of Health Care, a narrower term within Health Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Child Trends · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Jun 2023, registered Sep 2023).
  • Started Jun 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
14 Years to 18 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 134 studies in Patient Acceptance of Health Care with a site in United States — 24 open to participants now, 35 under way, 1 of them phase 3. Patient Acceptance of Health Care · United States.

Planned enrollment
22nd of 109
1,000 · median 264
Started
2023
with 16 others
No phase
100 of 134
21 open now
Primary completion
2026-03
later than 9 of 34 live
Registered
106th of 134
by date

Among the 134 studies in Patient Acceptance of Health Care with a site in United States, this one is the 22nd largest by planned enrollment of the 109 interventional ones that give a count, is one of 17 that started in 2023, is one of 100 with no phase, reaches primary completion later than 9 of the 34 other live ones, and was the 106th registered.

Patient Acceptance of Health Care

309 studies on the registry are indexed under Patient Acceptance of Health Care; 54 are open to participants now.

Browse Patient Acceptance of Health Care studies →

Open to participants now

24 of the 134 studies in Patient Acceptance of Health Care with a site in United States are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 34 Patient Acceptance of Health Care studies recruiting now, 22 (65%) set no upper age limit and 9 (26%) stop at 75 or younger; 11 take children under 18; 16 take healthy volunteers.

This study: 14 Years to 18 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 134 studies in Patient Acceptance of Health Care with a site in United States, or all of them as a file.
02

Study summary

The goal of this study is to evaluate the impact of SafeSpace Sexual Health App, an innovative sexual health promotion program focused on reducing sexual risk factors and promoting sexual and reproductive health and wellbeing among young people assigned female or intersex at birth, particularly Black and/or Latine youth, LGBTQ+ youth, youth in states with high teen birth rates and youth who live in rural communities. This study utilizes a two-arm randomized control trial design to measure impacts of receiving the SafeSpace Sexual Health program compared to receiving a similar-length control app program, SafeSpace General Health that focuses on general health.

The investigators will ask participants to:

  • Keep the SafeSpace app downloaded to their device and visit the app regularly over the course of 10 weeks.
  • Provide contact information.
  • Receive and open app push notifications for 10 weeks (up to 3 per week).
  • Complete 3 online surveys over a year: baseline, short-term follow-up (10 weeks after baseline), and long-term follow up (9 months after short-term follow-up).
  • Receive occasional text messages from the study team.
03

Conditions studied

  • Health Behavior
  • Health Care Utilization
  • Unprotected Sex
  • Sexually Transmitted Infections
04

In context

Patient Acceptance of Health Care Reclassified

309 studies on the registry are indexed under Patient Acceptance of Health Care; 54 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 202 across 218 interventional studies indexed under Patient Acceptance of Health Care.

Browse Patient Acceptance of Health Care studies →

Lead sponsor

Child Trends is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Compared within Patient Acceptance of Health Care, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Health Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be assigned female or intersex at birth
  • Participants must be youth in the U.S. (14-18 years old)
  • Participants must have daily access to an iPhone

Exclusion criteria

Exclusion Criteria:

  • Participants must not be currently pregnant or currently trying to become pregnant

Other Criteria:

  • The study's priority/preference population is for Black and/or Latine youth, LGBTQ+ youth, youth from geographic areas with high teen birth rates, and youth living in rural areas.
06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    SafeSpace Sexual Health

    The proposed intervention is a 10-week app-based program, SafeSpace Sexual Health. SafeSpace Sexual Health will be implemented using a secure, anonymous mobile app that uses authentic stories to engage young people with sexual health information and resources. The program addresses healthy relationships, anatomy and physiology, identity, adolescent development, STIs/HIV, pregnancy and reproduction, decision-making, personal safety, communication, and accessing healthcare. Each lesson includes a story written by youth with lived experience, two to three key facts developed by sexual health experts, a reflection prompt, and two to three reputable resources.

    Behavioral: SafeSpace Sexual Health

  • Active comparator
    SafeSpace General Health

    Participants in the control condition will participate in a 10-week app-based general health program, SafeSpace General Health. Lessons address general health topics including self-care, stress, sleep, nutrition, physical activity, substance use, driving and seatbelt use, and social media. Each lesson contains 2-3 key facts created by public health experts and reputable resources. Similar to SafeSpace Sexual Health, youth will receive SafeSpace General Health over 10 weeks, although SafeSpace General Health includes one lesson per week and does not contain youth stories or reflection prompts.

    Behavioral: SafeSpace General Health

Interventions

  • BehavioralSafeSpace Sexual Health

    The overall goal of the program is to prevent adolescent pregnancy and STIs by increasing sexual agency, increasing the use of condoms and contraception, and promoting healthy relationships and healthy life skills among adolescents.

  • BehavioralSafeSpace General Health

    This arm represents the comparison group. SafeSpace General Health will act as the active comparator, while providing youth with lessons, facts, and resources about general health topics.

07

What researchers measure

Primary outcomes

  1. Penile-vaginal sex without a condom or a more effective method of contraception

    Yes = Had penile-vaginal sex without using pill, shot, patch, ring, IUD, implant, or condom every time; No = Did not have penile-vaginal sex OR always used pill, shot, patch, ring, IUD, implant, or condom during penile-vaginal sex

    Time frame: Past 3 months at baseline; past 9 months at long-term follow-up

Secondary outcomes

  1. Penile-vaginal sex or anal sex without a condom every time

    Yes = Had penile-vaginal sex or anal sex without using a condom every time OR had anal sex without use of a condom every time. No = No penile-vaginal sex AND no anal sex; or No = No penile-vaginal sex AND condom use during anal sex every time; or No = condom use during every penile vaginal sex AND no anal sex

    Time frame: Past 3 months at baseline; past 9 months at long-term follow-up

  2. Utilization of sexual health services

    Yes = has seen a health care provider (clinic or doctor's office) for any sexual or reproductive health services in the past 12 months No = did not see a health care provider for SRH services in the past 12 months

    Time frame: Has received SRH services in the past 12 months or has an appointment scheduled in the next 3 months at baseline; Received SRH services in the past 9 months or has an appointment scheduled in the next 3 months at long-term follow-up.

  3. Number of Sexual and Reproductive Health topics discussed with a trusted adult in the past 3 months.

    Score of talking with trusted person in the past 3 months about topic categories including either sexual orientation or gender identity; when to have sex; receiving SRH services; STIs and contraception; consent or pleasure in the past 3 months. For this scale, there is a minimum score of 0 and a maximum score of 7 with a higher score indicating a better outcome

    Time frame: Past 3 months at baseline; past 10 weeks at short-term follow-up; past 9 months at long-term follow-up

  4. Sexual agency during every recent sexual experience or no recent sexual experiences

    Dependent on the frequency of a) communicating with their partners(s) about what they like, dislike, or want to try, b) asking their partner(s) what they like, dislike, or want to try, and c) asking or giving consent to their partner(s). Those who haven't engaged in sexual activity within the relevant time frame will be considered to have sexual agency

    Time frame: Past 3 months at baseline; past 10 weeks at short-term follow-up; past 9 months at long-term follow-up

08

Study locations

1 of 1 sites recruiting
  • Child Trends
    Bethesda, Maryland 20814, United States
    Recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Mar 2026, 32 months after the start.

Of 151 non-industry interventional studies with no phase under Patient Acceptance of Health Care, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's planned 32 months is above that.

Counting every sponsor, half of 154 studies reached it within 19 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2023
First posted
Sep 21, 2023
StartActual
Jun 12, 2023
Primary completionEst.
Mar 11, 2026
CompletionEst.
Sep 29, 2026
Last update
Nov 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06043596
Lead sponsor
Child Trends
Collaborators
Power to Decide, Healthy Teen Network, MyHealthEd, Inc
Responsible party
Sponsor
First posted
Sep 21, 2023
Start date
Jun 12, 2023
Primary completion
Mar 11, 2026 (estimated)
Completion
Sep 29, 2026 (estimated)
Last update
Nov 21, 2023

Study contacts

Elizabeth Cook, MSPH
Contact
ecook@childtrends.org
240-223-9323
Jennifer Manlove, PhD
Contact
jmanlove@childtrends.org
240-223-9262
Jennifer Manlove, PhD
study director · Child Trends
Elizabeth L Cook, MSPH
study director · Child Trends
Riley Steiner, PhD
principal investigator · Power to Decide

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion